ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
02 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
30 sept. 2020 17h04 HE
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...
ProPhase Labs Announces At-The-Market Equity Facility
23 sept. 2020 16h10 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has entered into an at-the-market (“ATM”) equity...
PROPHASE LABS, INC. ANNOUNCES SPECIAL CASH DIVIDEND
20 nov. 2019 16h15 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, PA, Nov. 20, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com), a vertically integrated manufacturer, marketer and distributor of a diversified range of...
ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2019
12 nov. 2019 09h35 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 12, 2019 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today reported net sales of $2.8 million for the three months ended...